Literature DB >> 2762216

An in vitro model to evaluate muscle damage following intramuscular injections.

G A Brazeau1, H L Fung.   

Abstract

An isolated rat muscle preparation was developed to screen for muscle damage (myotoxic potential) following intramuscular injections. Myotoxicity is evaluated by the total cumulative efflux of the enzyme creatine kinase from the extensor digitorum longus muscle into the incubation medium over a 2-hr period or by the slope of the cumulative creatine kinase efflux curve. The system allows for rapid screening of compounds and/or formulations regarding their myotoxic potential and is not sensitive to fluctuations of in vivo creatine kinase levels caused by animal handling or patient conditions. A good rank-order correlation was obtained between this in vitro technique and the in vivo myotoxicity of a number of pharmaceutical formulations, as indicated by circulating creatine kinase levels and histological observations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762216     DOI: 10.1023/a:1015940811827

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Reduction of enzyme efflux from skeletal muscle by diethylstilbestrol.

Authors:  R Dempsey; J Morgan; L Cohen
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

2.  Legitimate indications for intramuscular injections.

Authors:  P R Alper
Journal:  Arch Intern Med       Date:  1978-11

3.  Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration, and volume.

Authors:  F R Sidell; D L Culver; A Kaminskis
Journal:  JAMA       Date:  1974-09-30       Impact factor: 56.272

4.  Elevated serum CPK after drug injections.

Authors:  L Cacace
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

5.  Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions.

Authors:  K Korttila; A Sothman; P Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

6.  The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity.

Authors:  O Svendsen; F Rasmussen; P Nielsen; E Steiness
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-05

7.  The effect on serum enzymes of intramuscular injections of digoxin, bumetanide, pentazocine and isotonic sodium chloride.

Authors:  K E Andersen; T Damsgaard
Journal:  Acta Med Scand       Date:  1976

8.  An in vitro model for assessing muscle irritation due to parenteral antibiotics.

Authors:  P D Williams; B G Masters; L D Evans; D A Laska; G H Hottendorf
Journal:  Fundam Appl Toxicol       Date:  1987-07

9.  A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs.

Authors:  E Steiness; F Rasmussen; O Svendsen; P Nielsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-05

10.  Tests for local toxicity of intramuscular drug preparations: comparison of in vivo and in vitro methods.

Authors:  O Svendsen; F Højelse; R E Bagdon
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1985-02
View more
  5 in total

1.  Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.

Authors:  G A Brazeau; H L Fung
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Predicting injection site muscle damage. I: Evaluation of immediate release parenteral formulations in animal models.

Authors:  S C Sutton; L A Evans; M T Rinaldi; K A Norton
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  In vitro-in vivo myotoxicity of intramuscular liposomal formulations.

Authors:  S A al-Suwayeh; I R Tebbett; D Wielbo; G A Brazeau
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

4.  In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.

Authors:  G A Brazeau; S Attia; S Poxon; J A Hughes
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

Review 5.  Myotoxicity of injections for acute muscle injuries: a systematic review.

Authors:  Gustaaf Reurink; Gert Jan Goudswaard; Maarten H Moen; Adam Weir; Jan A N Verhaar; Johannes L Tol
Journal:  Sports Med       Date:  2014-07       Impact factor: 11.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.